Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene [5]

Journal of Clinical Psychopharmacology

Volumn 20, Issue 1, 2000, Pages 105-107

  Zanardi, R ^a   Benedetti, F ^a   Di Bella, D ^a   Catalano, M ^a   Smeraldi, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN TRANSPORTER;

ADULT; DEPRESSION; DNA POLYMORPHISM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; CARRIER PROTEINS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PAROXETINE; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SINGLE-BLIND METHOD;

EID: 0033984363     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200002000-00021     Document Type: Letter

References (12)